CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02529137
NCT02529137N/ACompleted

Pivotal Study for Validation of Philips Dx for Diagnosis in Surgical Pathology

Philips Digital & Computational Pathology·observational·Posted Aug 20, 2015·Updated May 28, 2021

In Brief

An observational study for Pathologic Processes. Completed, enrolled 2,000 participants across 4 sites.

Detailed Summary

The primary objective of this study is to show safety and effectiveness of the PDx for In Vitro Diagnostic (IVD) use as an aid to the pathologist to view, review and diagnose digital images of surgical pathology slides.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 20, 2015
Enrollment StartJul 1, 2015
Primary CompletionMay 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.9 years ago